News

Scale-up your small business with digital technologies

Join us to launch our next open call for industry projects funded by Innovate UK.

STFC are hosting a free event on 16th June for SMEs to launch a new programme funded by Innovate UK. This will offer SMEs funded, collaborative projects with our team of experts to help them adopt and scale up using HPC, AI and frontier technologies.

We would like to introduce ourselves: we are ResearchManager, a SaaS organisation offering a digital platform that supports clinical research teams by streamlining data collection, operational processes, and quality management. Founded in the Netherlands, we are now expanding into the United Kingdom to help life sciences organizations make clinical research more efficient, reliable, and faster, so they can bring treatments to patients more quickly.

Creative Biolabs, a global pioneer in antibody engineering, has introduced an integrated, end-to-end development ecosystem designed to streamline ADC design, synthesis, and preclinical validation.

Address the solid tumor bottleneck with advanced T-cell metabolic immunoengineering. Learn how structured CD8+ T-cell metabolic analysis and pathway modulation enhance mitochondrial fitness, prevent phenotype exhaustion, and accelerate the next-generation CAR-T therapeutic pipeline.

New initiative creates a single front door for businesses, investors and partners to collaborate with Newcastle University and drive economic growth.

Guardtech’s furniture & equipment specialists are providing elite hardware solutions for some of the leading lights in ground-breaking science and engineering sectors

Concept Life Sciences is pleased to announce a new strategic partnership with OpenBench, a pioneer of success-based AI hit discovery, to accelerate hit identification for biotech companies through a fee-for-success model.

Beyond strategy, Science and Innovation, the real competitive edge lies in your organisation's emotional chemistry. Trust, fear, ego – these invisible forces shape performance, and mastering them unlocks untapped potential.

Accelerate translational research with specialized iPSC solutions from Creative Biolabs. Access highly efficient reprogramming, precise genome editing, and directed differentiation services to build robust, reproducible in vitro disease models.

Many life sciences and biomedical businesses do not fail because the science is weak. They stall because there is a gap between technical development and commercial readiness. Understanding where you are in the journey, and what comes next, can make all the difference.

Creative Biolabs attended PEGS Boston last week, introducing a broad range of antibody-related solutions to support the work across oncology, immunology, biomarker discovery, and translational research.

A fantastic day of learning and hands-on experience was had by all during our training session on CRL’s Endosafe® nexgen-PTS™ System.

In 2026, sustainability pressure won’t come from regulators. It’ll come from your customers.

The healthcare sector drives ~5% of global emissions, with most coming from supply chains. Major players (AstraZeneca, GSK, Novartis and others) are aligning supplier requirements.

👉 This blog explains what’s changing, why now, and where to start

Firefinch Software publishes practical guidance to help instrumentation companies unlock GMP-regulated markets - and avoid the compliance pitfalls that slow scale-up.

Bionow recently took part in a UK-wide roundtable on procurement maturity in early-stage life sciences companies, alongside industry associations, government and investment stakeholders. As part of this ongoing work, we are inviting members to contribute to a short survey to help build a clearer picture of procurement practices across the sector.

Marketing has been evolving rapidly over the past couple of years, so it seems timely to share some of the biggest shifts I’ve seen shaping the effectiveness of marketing efforts. These are some of the most important areas, in my opinion, that should be high up on any marketer’s radar.

Award recognises LightOx’s LXD231 molecule, which is designed to eliminate antibiotic-resistant bacteria in wounds and which has potential applications in both clinical healthcare and military field medicine.

Ab Biotechnology packing up our first donations of micropipettes through the NHS Global Citizenship Programme – A fantastic initiative of Health Partnerships between volunteers from our NHS in Scotland and global health services around the world.

When a landing page sits away from your main domain, it can become an island — visible, perhaps, but disconnected from the strength of the website you’ve worked so hard to build. Instead of drawing power from your main site’s authority, internal links, content depth and brand trust, a subdomain landing page may have to prove itself almost from scratch.

Programme and Construction management specialist Axentia has delivered a new 2,500 sq ft Insect Quarantine Unit at York Biotech Campus, supporting Fera Science Ltd's advanced invertebrate research programme.

HMRC has significantly increased its scrutiny of R&D claims following concerns around error, abuse and poor-quality advice. Claims are now expected to be more detailed, better evidenced and clearly aligned with the definition of qualifying R&D.

The East Anglian cleanroom construction specialists have given their revolutionary ‘build your own cleanroom’ software a facelift to further enhance users’ procurement journey

Amiculum is delighted to become a member of Bionow and join this collaborative life sciences community that supports connection and knowledge sharing across the North of the UK.

At Ab Biotechnology, we’re proud of our commitment to sustainability and the circular economy. Recently, two surplus laboratory cabinets from one of our projects were given a second life — avoiding waste and supporting global research.

The pharmaceutical “super cliff” is no longer a future risk. It is now a present reality. As 2026 progresses, a major wave of patent expiries is underway, with an estimated $200 billion to $350 billion in annual revenue at stake. This cycle is not a repeat of the past. It reflects a fundamental shift toward complexity. Biologics, biosimilars and increasingly sophisticated intellectual property strategies are reshaping the landscape. The loss of exclusivity for semaglutide in several global markets highlights both the scale of the opportunity for generics and the urgency of the challenge for innovators.

A range of new funding calls from Innovate UK and partners are now open, spanning AI, advanced manufacturing, neurotechnologies and materials innovation - areas highly relevant to many Bionow members.

Mast Group are proud to be recognised for their contribution to bowel cancer screening receiving the Primary / Social Care Partnership Award at the Medilink North of England Healthcare Business Awards 2026, held on 30th April at Cutlers' Hall, Sheffield.

Following a successful launch last year, the Bionow BioAI Summit returned to Alderley Park on 29th April. The event welcomed over 100 delegates, speakers and exhibitors, all coming together to explore where artificial intelligence can deliver the most meaningful impact within the life sciences sector.

We’re excited to share EBSCO’s STM Source with our Bionow community members — a research tool designed specifically to support innovation within research and development teams, product management, and engineering departments.

The NIHR Invention for Innovation (i4i) Product Development Awards (PDA) programme is a key funding opportunity aimed at supporting the development of innovative medical technologies, digital health solutions and in vitro diagnostics.